glp 1 for cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists GLP-1 Receptor Agonists in the

Matthew R Hayes, Heath D Schmidt, GLP-1 influences food and drug reward, Current Opinion in Behavioral Sciences, Volume 9, 2016, Pages 66-70, ISSN 2352-1546 Hjerpsted JB, Flint A, Brooks A, Axelsen MB, Kvist T, Blundell J

While direct, peer-reviewed, head-to-head clinical trials comparing the two forms are still emerging, we can extrapolate a great deal from the known chemical properties

The short answer Nausea is one of the most common side effects we see with Wegovy, Zepbound, and other GLP-1 medications, and it is one of the most common reasons patients consider stopping

While every individuals metabolic rate differs, most patients follow a structured journey toward achieving their health goals